BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17096341)

  • 1. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
    Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
    Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
    Scélo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Tracey E; Brewster DH; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Brennan P
    Cancer Causes Control; 2007 Apr; 18(3):269-78. PubMed ID: 17237987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of second cancer after germinal cell testicular cancer: study from the data of Doubs cancer registry].
    Servagi-Vernat S; Langlois-Jacques C; Bontemps P; Cléro E; Bosset JF; Danzon A
    Bull Cancer; 2007 Jul; 94(7):721-6. PubMed ID: 17723956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
    Lerro CC; Robbins AS; Fedewa SA; Ward EM
    Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
    Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
    J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
    Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
    Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007).
    Andreassen KE; Grotmol T; Cvancarova MS; Johannesen TB; Fosså SD
    Int J Cancer; 2011 Dec; 129(12):2867-74. PubMed ID: 21626506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
    Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
    Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
    Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
    J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.